Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers

by Katarzyna Kurzątkowska, Manuel A. Pazos, Jason I. Herschkowitz, Maria Hepel
Published 2021-01-01

Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer

by Ali S. Ropri, Rebecca S. DeVaux, Jonah Eng, Sridar V. Chittur, Jason I. Herschkowitz
Published 2021-10-01

Interacting with tumor cells weakens the intrinsic clockwise chirality of endothelial cells

by Benson Hang, Eman Jassem, Hanan Mohammed, Leo Q. Wan, Jason I. Herschkowitz, Jie Fan
Published 2022-12-01

Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers

by Adam D. Pfefferle, Yash N. Agrawal, Daniel C. Koboldt, Krishna L. Kanchi, Jason I. Herschkowitz, Elaine R. Mardis, Jeffrey M. Rosen, Charles M. Perou
Published 2016-07-01

Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway

by Feng Bai, Chuying Wang, Xiong Liu, Daniel Hollern, Shiqin Liu, Cheng Fan, Chang Liu, Sijia Ren, Jason I. Herschkowitz, Wei-Guo Zhu, Xin-Hai Pei
Published 2022-03-01